Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of Children Aged 2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Retrospective Multicenter Study in 4 European Countries
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic disrupted respiratory syncytial virus (RSV) seasonality.
Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
Up to 25% of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit postacute cognitive sequelae.
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility
More than four years after the start of the COVID-19 pandemic, and the mass mobilization of the scientific community.
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
It is well-established that older adults are at increased risk of severe and fatal COVID-19, but the mechanisms underlying this susceptibility are not entirely clear.
COVID-19 vaccine strain updates: Global regulators agree on timing and data requirements
International regulators have published a report presenting the outcomes of a workshop on COVID-19 vaccine strain updates that was organised by the International Coalition of Medicines Regulatory Authorities and the World Health Organization.
News
Scientific Papers
Article
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
tudy using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults
News
Policy & Recommendations
Health emergency response governance in the EU after the COVID-19 pandemic
More than four years on since the start of the Covid-19 pandemic, this paper provides an assessment of reforms implemented at EU level to enhance the EU’s preparedness and response to future health threats.
Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months
Uptake of COVID-19 vaccines among pregnant individuals was hampered by safety concerns around potential risks to unborn children.